4th Digital Biomarkers and Clinical Measures in Neurology Summit

Key Topics

• Neurodegeneration & neuromuscular
• Neuropsychiatry & regulation
• Neurodegeneration
• Neuropsychiatry
• Evaluating motor symptomatic burden digitally for neuromuscular & neurodegenerative disease for more objective & quantitative assessment
• Advancements in digital speech analysis for neurological disorders: insights from psychiatry, parkinson’s & als
• Galvanizing cognition & sleep for more longitudinal assessment of patient improvement
• Defining the route to regulatory convergence, harmonization & standardization of digital measures in the cns
• Assessing commercial viability & scalability of digital biomarkers in the cns landscape
• Combining a battery of appoaches for epilepsy & als for more holistic & longitudinal monitoring of disease burden
• Patient perspectives on clinical relevance of digital biomarkers to neurological disease burden